Barclays Maintains Overweight on Zoetis, Raises Price Target to $260

Barclays analyst Balaji Prasad maintains Zoetis (NYSE:ZTS) with a Overweight and raises the price target from $250 to $260.

Barclays analyst Balaji Prasad maintains Zoetis (NYSE:ZTS) with a Overweight and raises the price target from $250 to $260.

Total
0
Shares
Related Posts
Read More

FY24 Defense Budget Proposal – Here’s Why Morgan Stanley Is Bullish On Defense Spending

Morgan Stanley analyst Kristine T Liwag, on the eve of the President’s FY24 budget request on March 9, spoke with a host of Defense and Government Services companies to know the pulse. The multiple management teams and industry experts suggested they expect to see about 3% - 5% growth in the topline above FY23 enacted levels.

BAH